-
Ziprasidone vs Other Atypical Antipsychotics for Schizophrenia
-
Psychotropic Therapy in Suicidal Adolescents: Effective in Reducing Readmission?
-
Antidepressant Efficacy Correlates With Depression Severity
-
CDC Commentary: Duchenne Muscular Dystrophy -- Considerations for Care
-
Omega-3 Fatty Acids in the Prevention of Psychotic Disorders?
-
Omega-3 Augmentation of Antidepressant in Patients With Coronary Heart Disease
-
AAPM 2009 Expert Video: A Primary Care Perspective
-
AAPM 2009 Expert Video: Multimodal Therapy in Pain
-
Atypical Antipsychotic Augmentation in Major Depressive Disorder
-
A Hospital Field Trip for the US Congress
-
Residential Alternatives to Psychiatric Hospital Admission
-
Morbidity and Mortality in Schizophrenia: The Mystery of Clozapine
-
Web-based Screening and Intervention Program May Reduce Drinking in University Students
-
Leading By Example to Fight H1N1 - Regina M. Benjamin, MD, MBA
-
Prevalence and Management of Pediatric Psychiatric Illness
-
Will the Recent CMS Ruling About Medical Consultation Change Medical Practices?
-
Antipsychotic Drugs and Risk for Hospitalization for Hyperglycemia in Elderly With Diabetes
-
Medication and Parent Training For Children With Pervasive Development Disorder
-
Medscape One-on-One: Rapidly Unfolding Health Information Technology
-
Buzz Words Surrounding Healthcare Reform
Earthquake in Haiti and the Medical Aftermath of Natural Disasters: Slideshow
Antipsychotics in Children and the Elderly: Controversies, Issues, and Ethics: Slideshow
Community Blogs
Commentary and Interviews
POLL
New research presented at this year's EPA meeting shows that cognitive behavioral therapy is as effective as hypnotic medications for patients with chronic insomnia. Do you prescribe cognitive behavioral therapy for your patients with chronic insomnia?
Advisory Board
Site Editorial Director
News Editor
- ABILIFY® (aripiprazole)
- ADHD treatment: Efficacy, insights, and dosing
- AMBIEN CR® (zolpidem tartrate extended-release CIV)
- Clinical Management Center
- GEODON® (ziprasidone HCI) Capsules
- Multiple considerations in depression treatment
- NEW INTUNIV" (guanfacine) Extended Release Tablets
- NUVIGIL® (armodafinil) Tablets [C-IV]
- PRISTIQ® (desvenlafaxine)
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
Also of Interest
- Coffee Associated With Lower Risk of Arrhythmias
- Physicians Say Onerous "Meaningful Use" Requirements Could Make EHR Incentives Meaningless
